Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tec Family Kinases in Inflammation and Disease
Nicole J. Horwood, Ania M. Urbaniak, Lynett Danks
International Reviews of Immunology (2012) Vol. 31, Iss. 2, pp. 87-103
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip J. Gotwals, Scott B. Cameron, Daniela Cipolletta, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 286-301
Closed Access | Times Cited: 866
PI3K signaling in cancer: beyond AKT
Evan C. Lien, Christian C. Dibble, Alex Toker
Current Opinion in Cell Biology (2017) Vol. 45, pp. 62-71
Open Access | Times Cited: 414
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean‐Baptiste Telliez, Martin E. Dowty, Lu Wang, et al.
ACS Chemical Biology (2016) Vol. 11, Iss. 12, pp. 3442-3451
Closed Access | Times Cited: 164
Back to the future: oral targeted therapy for RA and other autoimmune diseases
John J. O’Shea, Arian Laurence, Iain B. McInnes
Nature Reviews Rheumatology (2013) Vol. 9, Iss. 3, pp. 173-182
Open Access | Times Cited: 124
Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
Kata P. Szilveszter, Tamás Németh, Attila Mócsai
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 109
Interleukin-2-Inducible T-Cell Kinase (ITK) Deficiency - Clinical and Molecular Aspects
Sujal Ghosh, K. Bienemann, Kaan Boztuğ, et al.
Journal of Clinical Immunology (2014) Vol. 34, Iss. 8, pp. 892-899
Open Access | Times Cited: 102
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 25
Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Viktoria von Manstein, Yang Chul, Diane Richter, et al.
Current Signal Transduction Therapy (2014) Vol. 8, Iss. 3, pp. 193-202
Open Access | Times Cited: 73
B-cell selection and the development of autoantibodies
Natalia V. Giltiay, Craig P. Chappell, Edward A. Clark
Arthritis Research & Therapy (2012) Vol. 14, Iss. Suppl 4, pp. S1-S1
Open Access | Times Cited: 71
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
Vassilios Lougaris, Manuela Baronio, Massimiliano Vitali, et al.
Journal of Allergy and Clinical Immunology (2014) Vol. 133, Iss. 6, pp. 1644-1650.e4
Open Access | Times Cited: 63
Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis
Sebastian Torke, Martin S. Weber
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 10, pp. 1143-1150
Closed Access | Times Cited: 48
Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System
Mario Ernesto Cruz-Muñoz, Ezequiel M. Fuentes‐Pananá
Frontiers in Microbiology (2018) Vol. 8
Open Access | Times Cited: 43
The Non-receptor Tyrosine Kinase Tec Controls Assembly and Activity of the Noncanonical Caspase-8 Inflammasome
Florian Zwolanek, Michael Riedelberger, Valentina Stolz, et al.
PLoS Pathogens (2014) Vol. 10, Iss. 12, pp. e1004525-e1004525
Open Access | Times Cited: 42
Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants
Linda M. Hartkamp, Jay S. Fine, Inge E. van Es, et al.
Annals of the Rheumatic Diseases (2014) Vol. 74, Iss. 8, pp. 1603-1611
Closed Access | Times Cited: 42
Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
Yiming Zhong, Shuai Dong, Ethan Strattan, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 10, pp. 5960-5978
Open Access | Times Cited: 41
PI3Kβ—A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling
Anne R. Bresnick, Jonathan Backer
Endocrinology (2019) Vol. 160, Iss. 3, pp. 536-555
Open Access | Times Cited: 40
Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
Sujal Ghosh, Ingo Drexler, Sanil Bhatia, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 39
Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice
Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, et al.
Biochimie (2020) Vol. 179, pp. 146-156
Closed Access | Times Cited: 39
<p>Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?</p>
Ana Lorenzo-Vizcaya, Serena Fasano, David Isenberg
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 105-110
Open Access | Times Cited: 35
Hormonal stimulation reduces numbers and impairs function of human uterine natural killer cells during implantation
Jessica R. Kanter, Scott M. Gordon, Sneha Mani, et al.
Human Reproduction (2023) Vol. 38, Iss. 6, pp. 1047-1059
Open Access | Times Cited: 12
Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents
Alireza Alipour, Paria Farhadi, Kourosh Mobaraki, et al.
Journal of Molecular Structure (2025), pp. 141576-141576
Closed Access
Anti-inflammatory effects of Perilla frutescens in activated human neutrophils through two independent pathways: Src family kinases and Calcium
Chun‐Yu Chen, Yann‐Lii Leu, Fang Yu, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 40
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Activation Loop Dynamics Determine the Different Catalytic Efficiencies of B Cell– and T Cell–Specific Tec Kinases
R Joseph, Iivari Kleino, Thomas E. Wales, et al.
Science Signaling (2013) Vol. 6, Iss. 290
Open Access | Times Cited: 34
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton’s Tyrosine Kinase Inhibitors for Treatment of Rheumatoid Arthritis
Wataru Kawahata, Tokiko Asami, Takao Kiyoi, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 19, pp. 8917-8933
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top